Editorial
Published on 09 Sep 2025
Editorial: RAS inhibitor therapy of cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1685295
- 553 views
Type at least 3 characters
1,981 articles
Review
Published on 09 Sep 2025
Natural products targeting ferroptosis in cancer: molecular mechanisms and applications
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1588668
- 285 views
Original Research
Published on 08 Sep 2025
Outstanding treatment success of pembrolizumab and bevacizumab combination therapy in first-line treatment of cervical sarcomatoid carcinoma: a rare case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1586531
- 326 views
Case Report
Published on 08 Sep 2025
PEComa progressed by mTOR inhibitor therapy with anti-VEGFR TKI combined with PD-1 inhibitor: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1628650
- 290 views
Correction
Accepted on 05 Sep 2025
Correction: Editorial: Current status and recent advances in preclinical models for rare cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1697286
- 338 views
Review
Published on 05 Sep 2025
Application and development of Organ-on-a-Chip technology in cancer therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1643230
- 593 views
Original Research
Accepted on 04 Sep 2025
Mechanistic studies of miR-582-3p targeting of PTPRCAP affecting lung adenocarcinoma via the Wnt/β-catenin pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1652176
- 341 views
Original Research
Published on 04 Sep 2025
Dynamic alterations in m6A RNA methylation profiles during involution of infantile hemangiomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1652621
- 1,057 views
Mini Review
Accepted on 03 Sep 2025
The Role of Apelin in Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1683865
- 280 views
Review
Published on 03 Sep 2025
Research on the function of GPX4 in tumor-targeted treatment based on its molecular structure and features
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1594234
- 1,173 views
Perspective
Accepted on 02 Sep 2025
Role and prognostic value of oncostatin M and its receptor OSMR in acute myeloid leukemia, myeloproliferative neoplasms and non-hematological malignancies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1636570
- 224 views
Case Report
Published on 02 Sep 2025
Chronification of metastatic leiomyosarcoma in 9 lines of therapy by precision oncology: a case report and review of the literature
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1626478
- 330 views
Original Research
Published on 01 Sep 2025
Diaryl pyrimidine guanidine suppresses hepatocellular carcinoma cell stemness by targeting β-catenin signaling
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1641979
- 365 views
Original Research
Published on 01 Sep 2025
Evaluation of anti-liver cancer activity and anticancer mechanism of one novel small molecule compound (THY-10A62) targeting FAK pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1498005
- 429 views
Original Research
Published on 01 Sep 2025
MEX3A is a diagnostic, independent prognostic biomarker and a promising therapeutic target in glioblastoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1585592
- 594 views
Original Research
Published on 28 Aug 2025
NK cell-related genes-driven novel molecular subtyping and prognostic signatures for Wilms tumor: uncovering the therapeutic potential of TGX-221 and biomarker role of HS2ST1
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1593011
- 2,309 views